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ABSTRACT
Objective: To assess the pharmacists’ perception about their roles in tuberculosis (TB) control program in Medan, Indonesia.
Methods: A cross-sectional study was conducted to assess the pharmacists’ perception about their roles in TB control program in Medan, Indonesia 
using a validated questionnaire. The pharmacists involved in this study (n=117) were asked to choose answering yes, no or do not know for their 
perception on their roles in TB control program. The collected data consisted of demographics (gender, age, place of practice, and working experience) 
and the pharmacists’ perception on their roles in TB control program were organized and analyzed by applying descriptive and Chi-square analyses 
using Statistical Package for the Social Sciences (SPSS, version 19, Chicago, IL, USA) (p<0.05 was considered significant).
Results: Mean age of the participants was 38.6±11.7 (years). Most of them (76.1%) were female. Distribution of the participants by place of practice: 
Pharmacy, 78.6%; hospital, 20.5%. Most of them (63.2%) have heard about directly observed treatment short-course program. More than 90% of 
them realized that they could play their roles as providers, managers of anti-TB drugs, drug informants, ensurers for adherence to the TB treatment, 
educators for patients and publics on TB and its treatment. Only 26.5% of them knew that they could also play their role as inventors of early 
suspected TB in the community.
Conclusion: The study proved that the pharmacists’ roles could be utilized and enhanced to optimize TB control programs in Indonesia.
Keywords: Pharmacists’ role, Tuberculosis, Directly observed treatment short-course program.
INTRODUCTION
Tuberculosis (TB) remains as one of the major global public health 
problems because of its increasing prevalence along with the increasing 
of endemic diseases especially in Asian countries. Indonesia was ranked 
as the fourth largest country with TB incidence in the world following 
India, China, and South Africa. Among all infectious diseases, TB was the 
second global leading cause of death following human immunodeficiency 
virus [1]. In 2014, as many as 1,600,000 people in Indonesia were 
diagnosed as having TB with mortality rate of 100,000 [2]. Even though 
significant progresses have been made, yet efforts must be continuously 
done to support the vision of a world free of TB.
Successful prevention and care of TB are determined by many complex 
factors. All elements of societies including governments, health-care 
providers (doctors, nurses, and pharmacists), nongovernmental 
organizations, community leaders, religious leaders as well as publics 
must be fully involved in the prevention and ensuring the success of 
TB treatment. Pharmacists could play important roles in the prevention 
and management of TB. These roles include provision of adequate TB 
drugs, improvement of the TB patients’ adherence to their prescribed 
medications, and patient education about TB and its treatment [3]. To 
implement these roles, pharmacists must realize the importance of 
their roles, have enough knowledge, and participate in the prevention 
and treatment programs of TB [4].
The contribution of pharmacists in prevention and treatment programs 
of TB varies across countries. In few countries, pharmacists have served 
as the frontline health-care providers and often a first point of contact 
for people with symptoms of TB such as cough [4]. A study showed that 
the involvement of pharmacists in TB treatment improved patients’ 
adherence to the prescribed TB medications and directly improved 
therapeutic outcomes [5]. Many studies on TB have also been undertaken 
in Indonesia. However, studies on the role of pharmacists in prevention 
and treatment of this disease are still limited. A study on knowledge 
of pharmacists’ role which involved 17 pharmacists as participants in 
TB control performed in Yogyakarta indicated that there was a lack of 
knowledge about the roles of the pharmacists in TB control [6].
Involvement of pharmacists in TB control in Indonesia is still limited. 
It is hoped by the Department of health Province of Sumatera Utara 
and Health Office of Medan that the pharmacists who practice in this 
area enhance their contribution in the prevention and treatment of TB. 
To response to these issues, this study focused on assessment of the 
pharmacists’ perception about their roles in TB control program in 
Medan.
METHODS
A cross-sectional study was undertaken to assess the pharmacists’ 
perception about their roles in TB control program in Medan. The 
pharmacists recruited as participants in this study were only limited 
to whom directly interact with TB patients in various health facilities 
including pharmacies, hospitals, and clinics (n=117). Ethical approval 
was obtained from the Ethical Committee, School of Nursing University 
of Sumatera Utara, Indonesia. A validated questionnaire [6,7] was 
distributed to the participants. They were asked to choose yes or no 
whether they have heard about directly observed treatment short-
course (DOTS) and yes, no or do not know for their roles as care and 
drug information providers, teamwork of health-care providers, 
supervisors for anti-TB selection, early inventors of suspected TB 
patients, implementers to improve TB patients’ adherence to their 
medications, educators for patients and people on TB and its treatment, 
and monitoring drug therapy. The participants were allowed for about 
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15 minutes to answer all questions. The collected data consisted of 
demographics (gender, age, place of practice, and working experience) 
and their perceptions on their roles in TB control program were analyzed 
by applying descriptive and Chi-square analyses using Statistical 
Package for the Social Sciences (SPSS, version 19, Chicago, IL, USA) 
(p<0.05 was considered significant).
RESULTS
As many as 117 pharmacists were recruited as participants in the study. 
Characteristics of the participants by gender, age, place of practice, and 
working experience are shown in Table 1. Mean age of the participants 
was 38.6±11.7 (years). As demonstrated in Table 1, the majority of 
the participants (76.1%) were female. According to the participants’ 
distribution by health facility, it was found that most of them (78.6%) 
practice in pharmacies. Less than a quarter of them (20.5%) practice in 
hospitals. The participants’ working experience was 9.45±8.4 (years). 
Most of the participants have worked for less of 10 years.
Understanding on DOTS program and sources of information obtained 
by the participants are listed in Table 2. This study proved that 
74 (63.2%) of the pharmacists have heard and known about DOTS 
program. Of the 74 participants, as many as 30 participants (40.5%) 
and 27 participants (36.5%) got information about DOTS program 
through seminars and formal education at universities, respectively. 
As many as 43 (36.8%) of them have still never heard about the DOTS 
program.
The pharmacists’ perception about their roles in TB control program is 
listed in Table 3. This study indicated that almost all of the pharmacists 
(97.4%) argued that they could provide and manage the use of anti-TB 
medicines. Most of them (97.4%) also realized that they could provide 
information on anti-TB medicines. Most of the pharmacists (81.2%) 
realized that they should integrate and collaborate with other health-
care providers in the care of TB patients. This study found that 77.8% 
of the pharmacists realized that they could serve as supervisors for TB 
patients regarding their medications as homecare services. Most of the 
participants (91.5%) knew that they could play an important role to 
ensure compliance of TB patients with their medications.
With respect to the pharmacists’ role as educators, it was proved that 
94.9% of them realized that they could monitor and educate patients 
about the side effects of anti-TB drugs. The majority of the participants 
(90.6%) were aware of the importance of their involvement to educate 
publics on TB and its treatment. In addition, this study also proved 
that 78.6% of the participants realized that they could monitor the 
distribution and use of TB drugs in communities. Less than one-third of 
the participants (26.5%) realized that they could play important role as 
an early inventor of TB patients in communities.
DISCUSSIONS
DOTS is the strategy recommended by the World Health Organization 
in the prevention and treatment of TB worldwide. The DOTS program 
ensures that patients take each dose of anti-TB medication as prescribed 
and helps prevent the emergence of drug resistance [8,9]. Promotion 
of adherence to the prescribed TB medication is implemented through 
a patient-centered approach includes facilitating access to treatment, 
choosing with the patients’ most convenient time and place for 
direct observation of treatment, and when possible, providing other 
social and medical services [10]. Pharmacists as a part of health-care 
providers should know, understand, and participate in the DOTS 
program. Findings on the pharmacists’ perceptions on their role on TB 
management vary from one study to another.
As previously mentioned only 63.2% of the pharmacists have known 
about DOTS program from different sources of information. This means 
improvement of the participants’ understanding on DOTS program is 
required. In the future, policy makers should place priority on improving 
the pharmacists’ knowledge on TB. In the TB control programs, all 
Table 3: Pharmacists’ perception about their roles in TB control 
program (n=117)
Roles of pharmacists Pharmacists’ perception n (%)
Yes No Do not 
know
To provide and manage the 
use of anti-TB medicines
114 (97.4) 1 (0.9) 2 (1.7)
To provide information on 
anti-TB medicines
114 (97.4) 0 3 (2.6)
To integrate and collaborate 
with other health-care 
providers in the care of TB 
patients
95 (81.2) 14 (12.0) 8 (6.8)
Supervisors to the TB patients 
regarding their medications
91 (77.8) 21 (17.9) 5 (4.3)
Early inventors of patients 
with suspected TB
31 (26.5) 72 (61.5) 14 (12.0)
To improve adherence of TB 
patients to their medications
107 (91.5) 8 (6.8) 2 (1.7)
To monitor and educate 
patients about side effects of 
TB medications
111 (94.9) 3 (2.6) 3 (2.6)
To monitor the distribution 
and use of TB drugs in 
communities
92 (78.6) 17 (14.5) 8 (6.8)
To educate people on TB and 
its treatment
106 (90.6) 5 (4.3) 6 (5.1)
To monitor drug therapy 104 (88.9) 10 (8.5) 3 (2.6)
TB: Tuberculosis
Table 1: Characteristics of the participants by gender, age, place 
of practice, and working experience (n=117)
Variable Category Frequency n (%) p
Gender Female 89 (76.1) <0.001
Male 28 (23.9)









1-10 years 76 (65.0) <0.001
11-20 years 31 (26.5)
21-30 years 8 (6.8)
30-40 years 2 (1.7)
Table 2: Understanding on DOTS program and sources of 
information obtained by the participants (n=117)
Variable Category Frequency
n (%)
Have heard about DOTS Yes 74 (63.2)
No 43 (36.8)





Others (Hospital, Clinic, etc.) 14 (18.9)
DOTS: Directly observed treatment short-course
elements of society including pharmacists must have roles [11]. 
A pharmacist plays an important role in TB control, especially in 
aspects related to the provision and use of TB medicines [3]. According 
to this study, nearly all of the pharmacists argued that they could 
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manage the use of anti-TB medicines and provide information about 
the medicines. The results of this study are consistent with the previous 
study conducted in Yogyakarta in which all participants in both studies 
were aware that they had pivotal roles to provide accurate selection of 
efficacious and safe TB drugs as well as drug information to patients 
with TB [6].
Most of the pharmacists (81.2%) realized that they should integrate and 
collaborate with other health-care providers in the care of TB patients. 
This finding is slightly different from a previous study undertaken in 
Yogyakarta. The previous study found that all participants knew that they 
must collaborate with other health-care providers in the care and control 
of TB [6]. The Indonesian government has urged all health-care providers 
and publics to collaborate in TB control programs in Indonesia [11].
This study found that most of the pharmacists realized that they 
could serve as supervisors to ensure that the patients adhere and 
comply with their medications as homecare services. This finding 
supported a study undertaken in Yogyakarta that revealed that one of 
the pharmacists’ roles was to guarantee and ensure compliance of TB 
patients with their medications [6]. Nonadherence to the prescribed 
TB medications is one of the risk factors for development of multi-drug 
resistant TB (MDR-TB) which in turn requires the more expensive and 
toxic medications which may finally result in treatment failure [12,13]. 
It has been found that Indonesia is one of the 27 MDR-TB high burden 
countries worldwide, with estimated 6,800 new cases every year. The 
national MDR-TB prevalence is estimated at 1.9% among new TB cases 
and 12% any retreatment TB cases [14]. A prospective study conducted 
in India found that provision of counseling to TB patients (n=39) 
improved their adherence to their medications [15]. Thus, Indonesian 
pharmacists should also be encouraged to involve in improving the TB 
patients’ adherence to their medications.
With respect to the pharmacists’ role as educators, it was proved that 
most of them realized that they could monitor and educate patients 
about the side effects of anti-TB drugs. A similar also proved that 
another pharmacists’ role was to monitor and educate patients about 
the side effects associated with the use of TB medicines [6]. Awareness 
of this role is important, because the TB patients need information 
about side effects of their medications and what actions to be taken 
to resolve these problems. A study on the prevalence of adverse drug 
reactions experienced by TB patients in a tertiary care hospital in India 
showed that the majority of the patients had the wrong opinion about 
their treatments because they felt that their conditions were worsened 
after taking TB drugs [16]. Thus, sufficient knowledge of TB patients 
about their medications is important. The majority of the participants 
(90.6%) were aware of the importance of their involvement to educate 
publics on TB and its treatment. Curing the individual patient and 
minimizing the transmission of Mycobacterium tuberculosis to other 
persons are the main strategy to manage TB in the community. Thus, 
successful treatment of TB has benefits both for the individual patient 
and the community in which the patient resides [17]. In addition, most 
of the participants realized that they could monitor the distribution 
and use of TB drugs in communities. These findings indicated that 
the pharmacists have the capacity to contribute to TB program. In 
reality, this potency remains underutilized. To realize this potential, 
the Department of Health needs to collaborate with the Indonesian 
Pharmacist Association and other organizations to establish strategies 
with regulatory enforcement.
This study indicated that less than one third of the participants realized 
that they could play important role as an early inventor of TB patients 
in communities. A systematic review on delays in diagnosis and 
treatment of pulmonary TB in India found that pharmacies were the 
first health-care providers visited by TB suspect patients before visiting 
a diagnostic facility or medical practitioner [18]. Early detection of TB 
patients is important for early treatment and avoidance of the disease 
transmission. This finding must be highlighted and considered for the 
future policy of TB prevention and treatment to support the vision of 
the world free of TB.
CONCLUSIONS
Based on this study, it could be concluded that most of the pharmacists 
realized that they could play important roles in the prevention and 
care of TB especially in providing and management of TB medications, 
patients’ adherence, monitoring of anti-TB medications and their 
side effects. It should be highlighted by the policy makers that the 
pharmacists’ potency should be utilized and enhanced especially in 
early detection of TB cases in communities to optimize TB care and 
control.
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